Find out how AI influences drug discovery, enabling earlier predictions and reducing the risks in clinical development.

As biological data volume continues to grow, sequence-based AI is poised to become the dominant discovery layer across pharma ...

Eli Lilly and Nvidia are partnering to build what the companies call the pharmaceutical industry's "most powerful" supercomputer and so-called AI factory to help accelerate drug discovery and ...

Explore the role of transcription factor biology in drug discovery and how it impacts our understanding of disease mechanisms ...

In the rapidly evolving field of drug discovery, single-cell analysis has become an invaluable tool for understanding cellular heterogeneity and molecular pathways. However, traditional single-cell ...

A new drug discovery paradigm Enki is purpose-built for small-molecule drug discovery (Fig. 1). Fully trained on millions of data points including curated molecular structures, bioactivity profiles ...

In the face of US federal funding cuts, biomedical researchers propose strategies for continued progress in drug discovery. Publishing in Trends in Pharmacological Sciences, their recommendations ...

Computational drug discovery and design integrates advanced computer‐aided methodologies with chemical and biological insights to accelerate the identification and optimisation of therapeutic agents.

Nvidia is no longer content to be the chip supplier behind other companies’ biotech ambitions. With a multibillion dollar ...

ANN ARBOR, Mich. & NEW YORK--(BUSINESS WIRE)--A new partnership between the University of Michigan (U-M) and health care investment firm Deerfield Management Co. will create a company to commercialize ...